Merck Expands Bengaluru Manufacturing Hub with €13 Million Investment
Merk has expanded its manufacturing facility in Jigani, Bengaluru, to support India's growing life science sector and customers across the Asia-Pacific region. The company is investing €13 million in the site to strengthen regional manufacturing and expand biology and chemistry capabilities.
The expansion will add biological buffer manufacturing to the site's established chemistry capabilities, providing customers with an integrated offering from research through commercial production.
Merk's Bengaluru hub will manufacture biological buffers and raw materials for diagnostic applications used in DNA research, cell culture, diagnostics, and drug manufacturing. This will help improve supply reliability, reduce import dependence, and enable faster responses to customer needs.
The facility has reserved 34% of its site area for greenbelt, including trees and vegetation that support environmental protection and sustainable operations.